MedPath

AJANTA PHARMA LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:2
Completed:4

Trial Phases

2 Phases

Phase 3:14
Phase 4:2

Drug Approvals

141

PHILIPPINES:138
SFDA:2
FDA:1

Drug Approvals

RIVASTIGMINE TARTRATE

Approval Date
Feb 19, 2018
FDA

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Phase 3
14 (87.5%)
Phase 4
2 (12.5%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.